Indivior (INDV) News Today → This TSLA short trade is on a nine win hot streak (From WealthPress) (Ad) Free INDV Stock Alerts GBX 1,434 +6.00 (+0.42%) (As of 06:36 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 23, 2024 | marketwatch.comIndivior Shareholders Approve Main Listing Switch to U.S.May 1, 2024 | lse.co.ukLondon open: FTSE edges higher ahead of Fed; Nationwide data in focusApril 26, 2024 | finance.yahoo.comWhy Indivior PLC (LON:INDV) Looks Like A Quality CompanyApril 25, 2024 | marketbeat.comIndivior (LON:INDV) Sets New 52-Week High at $145,300.00Indivior (LON:INDV) Reaches New 12-Month High at $145,300.00April 14, 2024 | nasdaq.comNotable Two Hundred Day Moving Average Cross - INDVMarch 20, 2024 | insidertrades.comIndivior PLC (LON:INDV) Insider Sells £170,577.33 in StockMarch 19, 2024 | marketbeat.comMark Crossley Sells 10,549 Shares of Indivior PLC (LON:INDV) StockIndivior PLC (LON:INDV - Get Free Report) insider Mark Crossley sold 10,549 shares of the stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of GBX 1,617 ($20.59), for a total transaction of £170,577.33 ($217,157.64).March 19, 2024 | insidertrades.comIndivior PLC (LON:INDV) Insider Mark Crossley Sells 15,444 SharesMarch 12, 2024 | msn.comThis Nasal Spray Rapidly Reverses Effects Of Fentanyl Overdose And No, It's Not NaloxoneFebruary 29, 2024 | markets.businessinsider.comIndivior Says Final Court Approval Concludes Antitrust Multidistrict LitigationFebruary 24, 2024 | reuters.comEurope's STOXX 600 at all-time high as Nvidia boosts global tech sharesFebruary 22, 2024 | msn.comIndivior weighs moving primary listing to U.S.February 10, 2024 | finance.yahoo.comIndivior PLC (LON:INDV) Shares Could Be 44% Below Their Intrinsic Value EstimateJanuary 18, 2024 | markets.businessinsider.comAdial Announces Appointment of Tony Goodman as Chief Operating OfficerNovember 20, 2023 | finance.yahoo.comGreat week for Indivior PLC (LON:INDV) institutional investors after losing 22% over the previous yearNovember 9, 2023 | msn.comIndivior PLC (INDV) Tops Q3 Earnings and Revenue EstimatesOctober 2, 2023 | finance.yahoo.comIndivior PLC (INDV): Unveiling Its Market ValueSeptember 26, 2023 | finance.yahoo.comIndivior Publishes Real World Data Showing SUBLOCADE® May Reduce Non-Fatal Overdoses Among Individuals with Opioid Use Disorder in CanadaSeptember 7, 2023 | finance.yahoo.comIndivior PLC (INDV)'s True Worth: A Complete Analysis of Its Market ValueJune 12, 2023 | finance.yahoo.comThe 7.5% return this week takes Indivior's (LON:INDV) shareholders three-year gains to 372%June 12, 2023 | finance.yahoo.comIndivior to Commence Trading on NasdaqJune 7, 2023 | msn.comJefferies Reiterates Indivior (LSE:INDV) Buy RecommendationJune 5, 2023 | reuters.comIndivior opioid settlement makes purer M&A caseJune 3, 2023 | msn.comUS drugmaker Indivior to pay $102.5 million to settle Suboxone monopoly claimsJune 2, 2023 | finanznachrichten.deIndivior PLC: Indivior Reaches Agreement with States' Attorneys General and District of Columbia to Resolve Antitrust Multi-District Litigation ClaimsMay 25, 2023 | uk.finance.yahoo.comINDV.L - Indivior PLCMay 25, 2023 | finance.yahoo.comIndivior To Participate In Upcoming Investor ConferencesMay 23, 2023 | finance.yahoo.comIndivior PLC Form 20-F Registration Statement for Additional US Listing Now Available; Trading on NASDAQ Expected to Commence on June 12thMay 22, 2023 | markets.businessinsider.comFDA Approves Opiant's Nasal Spray 'Opvee' To Reverse Opioid OverdoseMay 22, 2023 | reuters.comUS FDA approves Opiant's spray for reversing opioid-related overdosesMay 22, 2023 | finance.yahoo.comIndivior Announces U.S. Food and Drug Administration Approval of OPVEE® (nalmefene) Nasal Spray, An Opioid Overdose Rescue Medicine for Natural and Synthetic Opioids Like FentanylApril 27, 2023 | finance.yahoo.comIndivior Announces Q1 2023 Financial ResultsApril 25, 2023 | finance.yahoo.comIndivior To Participate In Bank of America Global Healthcare Conference 2023March 2, 2023 | finance.yahoo.comIndivior Completes Acquisition of Opiant Pharmaceuticals, Inc.February 16, 2023 | finance.yahoo.comFY 2022 Financial Results AnnouncedFebruary 6, 2023 | finance.yahoo.comOpiant Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition by Indivior PLCJanuary 2, 2023 | finance.yahoo.comInvesting in Indivior (LON:INDV) three years ago would have delivered you a 861% gainDecember 9, 2022 | finance.yahoo.comShould You Be Excited About Indivior PLC's (LON:INDV) 73% Return On Equity?December 7, 2022 | finance.yahoo.comIndivior Capital Markets Day Highlights Strategy for Shareholder Value Creation and Attractive Medium-Term Profitable Growth OutlookNovember 14, 2022 | finance.yahoo.comIndivior To Acquire Opiant PharmaceuticalsNovember 8, 2022 | finance.yahoo.comIndivior Third Quarter 2022 Earnings: EPS: US$0.29 (vs US$0.18 in 3Q 2021)October 27, 2022 | finance.yahoo.comIndivior Announces Q3 2022 Financial ResultsOctober 11, 2022 | finance.yahoo.comIndivior PLC (LON:INDV) is favoured by institutional owners who hold 86% of the companySeptember 30, 2022 | finance.yahoo.comIndivior Shareholders Approve Resolutions to Proceed with Additional U.S. ListingSeptember 27, 2022 | businesswire.comAelis Farma: Availability of the 2022 Half-year Financial Report - Business WireSeptember 26, 2022 | law360.comTwo Funds Seek Invidior Antitrust Docs In Securities Case - Law360September 7, 2022 | finance.yahoo.comIndivior To Participate in Upcoming Investor Healthcare EventsSeptember 5, 2022 | thetimes.co.ukReckitt boss’s in-tray is still bulging | Business - The TimesSeptember 1, 2022 | prnewswire.comIndivior Recognizes National Recovery Month, Commits to Helping Move People living with Opioid Use Disorder onto a Path to Hope and Recovery - PR NewswireAugust 30, 2022 | nasdaq.comIs EDAP TMS (EDAP) Outperforming Other Medical Stocks This Year? - Nasdaq Get Indivior News Delivered to You Automatically Sign up to receive the latest news and ratings for INDV and its competitors with MarketBeat's FREE daily newsletter. Email Address Look what happened to Netflix during these “Hotspot Dates” (Ad)We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates” But if you want the stock with “Hotspot Dates” hitting NEXT WEEK… INDV Media Mentions By Week INDV Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INDV News Sentiment▼0.000.79▲Average Medical News Sentiment INDV News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INDV Articles This Week▼10▲INDV Articles Average Week Get Indivior News Delivered to You Automatically Sign up to receive the latest news and ratings for INDV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: HUTCHMED News Hikma Pharmaceuticals News Genus News EMIS Group News Spire Healthcare Group News Oxford Nanopore Technologies News Craneware News Ergomed News PureTech Health News Advanced Medical Solutions Group News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:INDV) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaA once-in-a-century investment opportunityStansberry ResearchWrite this ticker symbol down…StocksToTradeMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Indivior PLC Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
